ICCC EBITDA | ImmuCell Corporation

ImmuCell Corporation (ICCC) EBITDA

2026-06-30: Basis Reported; EBITDA $2.41M; Operating income (m); Depreciation and amortization (m).
2026-03-31: Basis Reported; EBITDA $2.5M; Operating income (m); Depreciation and amortization (m).
2025-12-31: Basis Reported; EBITDA $651,516.00; Operating income (m); Depreciation and amortization (m).
2025-09-30: Basis Reported; EBITDA $728,742.00; Operating income (m); Depreciation and amortization (m).

Complete source-backed ebitda history.

Available history: 2024-09-30 to 2026-06-30
Data captured: 2026-09-04

Historical EBITDA

EBITDA 3 month

Date	Basis	EBITDA	Operating income	Depreciation and amortization	Revenue	EBITDA margin	Capital spending	Operating cash flow	Cost of products and services	Research and development	Selling, general and administration	Income tax expense / benefit
2026-06-30	Reported	$2.41M	(m)	(m)	(m)	33.48%	$733.94K*	$3.02M*	(m)	$119.65K	(m)	$45.95K
2026-03-31	Reported	$2.5M	(m)	(m)	(m)	24.14%	$177.23K	$3.57M	(m)	$317.69K	(m)	$12.52K
2025-12-31	Reported	$651,516.00	(m)	(m)	(m)	8.54%	(m)	(m)	(m)	(m)	(m)	(m)
2025-09-30	Reported	$728,742.00	(m)	(m)	(m)	13.24%	$593.92K*	-$1.18M*	(m)	$694.31K	(m)	$4.46K
2025-06-30	Reported	$1.25M	(m)	(m)	(m)	19.37%	$155.16K*	$1.60M*	$3.63M	$831.86K	(m)	$1.90K
2025-03-31	Reported	$1.8M	(m)	(m)	(m)	22.37%	$329.05K	$1.57M	$4.71M	$756.85K	(m)	$1.90K
2024-12-31	Reported	$1.31M	(m)	(m)	(m)	16.85%	(m)	(m)	(m)	(m)	(m)	(m)
2024-09-30	Reported	$111,033.00	(m)	(m)	(m)	1.85%	$88.41K*	-$639.33K*	$4.43M	$786.14K	(m)	$1.34K
2024-06-30	Reported	(m)	-$1.39M	(m)	(m)	(m)	$110.74K*	$581.78K*	$4.24M	$1.03M	(m)	$1.34K
2024-03-31	Reported	(m)	-$300.05K	(m)	(m)	(m)	$70.36K	$418.50K	$4.96M	$1.26M	(m)	$1.34K
2023-09-30	Reported	(m)	-$1.18M	(m)	$5.40M	(m)	$420.51K*	-$507.75K*	$4.13M	$1.12M	(m)	$229.00
2023-06-30	Reported	(m)	-$1.30M	(m)	(m)	(m)	$708.49K*	-$681.43K*	$2.49M	$1.10M	(m)	$1.52K
2023-03-31	Reported	(m)	-$2.26M	(m)	(m)	(m)	$682.17K	-$2.76M	$3.15M	$1.11M	(m)	$1.52K
2022-09-30	Reported	(m)	-$616.79K	(m)	$4.80M	(m)	$734.31K*	-$1.26M*	$2.95M	$1.27M	(m)	$3.87K
2022-06-30	Reported	(m)	-$619.01K	(m)	(m)	(m)	$943.29K*	$373.46K*	$2.15M	$1.14M	(m)	$1.15K
2022-03-31	Reported	(m)	$570.61K	(m)	(m)	(m)	$807.50K	$638.53K	$2.90M	$1.04M	(m)	$1.15K
2021-09-30	Reported	(m)	$271.09K	(m)	$5.15M	(m)	$675.40K*	$258.99K*	$2.73M	$1.05M	(m)	$8.04K
2021-06-30	Reported	(m)	$215.51K	(m)	(m)	(m)	$879.34K*	$730.83K*	$2.47M	$1.00M	(m)	(m)
2021-03-31	Reported	(m)	-$374.63K	(m)	(m)	(m)	$349.32K	-$623.55K	$2.50M	$1.03M	(m)	(m)
2020-09-30	Reported	(m)	-$251.60K	(m)	(m)	(m)	$1.47M*	-$667.33K*	$2.00M	$1.12M	(m)	$0.00*
2020-06-30	Reported	(m)	-$691.27K	(m)	(m)	(m)	$1.06M*	$969.20K*	$1.68M	$1.09M	(m)	$0.00*
2020-03-31	Reported	(m)	$196.88K	(m)	(m)	(m)	$1.25M	$857.45K	$2.67M	$974.43K	(m)	-$14.63K
2019-09-30	Reported	(m)	-$429.82K	(m)	(m)	(m)	$399.88K*	-$66.41K*	$1.52M	$984.73K	(m)	$7.44K
2019-06-30	Reported	(m)	-$546.93K	(m)	(m)	(m)	$105.73K*	-$330.66K*	$1.46M	$820.05K	(m)	$15.33K
2019-03-31	Reported	(m)	$265.30K	(m)	(m)	(m)	$194.40K	$677.20K	$2.21M	$910.37K	(m)	$9.02K
2018-09-30	Reported	(m)	-$149.14K	(m)	(m)	(m)	$215.97K*	-$505.94K*	$1.20M	$908.79K	(m)	-$5.60K
2018-06-30	Reported	(m)	-$193.41K	(m)	$3.01M	(m)	$501.93K*	$21.22K*	$1.53M	$761.89K	(m)	$501.82K
2018-03-31	Reported	(m)	-$178.16K	(m)	$2.88M	(m)	$1.21M	$249.66K	$1.52M	$582.93K	(m)	-$49.15K
2017-09-30	Reported	(m)	-$482.41K	(m)	(m)	(m)	$4.46M*	-$255.12K*	$1.07M	$585.83K	(m)	-$192.30K
2017-06-30	Reported	(m)	-$265.31K	(m)	$1.75M	(m)	$3.68M*	-$155.12K*	$828.25K	$387.01K	(m)	-$83.31K
2017-03-31	Reported	(m)	$918.21K	(m)	$3.54M	(m)	$4.93M	$1.26M	(m)	$339.62K	(m)	$303.73K
2016-12-31	Reported	(m)	$119.31K	(m)	(m)	(m)	(m)	(m)	(m)	$253.74K	(m)	(m)
2016-09-30	Reported	(m)	$50.47K	(m)	(m)	(m)	$1.10M*	-$117.92K*	(m)	$307.72K	(m)	-$10.91K
2016-06-30	Reported	(m)	$21.46K	(m)	(m)	(m)	$379.80K*	$253.30K*	(m)	$380.43K	(m)	-$679.00
2016-03-31	Reported	(m)	$698.96K	(m)	(m)	(m)	$311.48K	-$87.24K	(m)	$302.44K	(m)	$223.13K
2015-12-31	Reported	(m)	$461.44K	(m)	(m)	(m)	(m)	(m)	(m)	$331.14K	(m)	(m)
2015-09-30	Reported	(m)	$626.85K	(m)	(m)	(m)	$337.89K*	$552.12K*	(m)	$301.75K	(m)	$260.45K
2015-06-30	Reported	(m)	$213.98K	(m)	(m)	(m)	$445.74K*	$116.24K*	(m)	$271.76K	(m)	$113.43K
2015-03-31	Reported	(m)	$820.05K	(m)	(m)	(m)	$988.46K	$1.40M	(m)	$330.67K	(m)	$335.52K
2014-12-31	Reported	(m)	$198.86K	(m)	(m)	(m)	(m)	(m)	(m)	$462.96K	(m)	(m)
2014-09-30	Reported	(m)	$40.85K	(m)	(m)	(m)	$207.49K*	-$279.41K*	(m)	$361.23K	(m)	$19.28K
2014-06-30	Reported	(m)	-$458.67K	(m)	(m)	(m)	$267.80K*	$25.03K*	(m)	$760.67K	(m)	-$179.87K
2014-03-31	Reported	(m)	$12.56K	(m)	(m)	(m)	$44.85K	$304.84K	(m)	$594.21K	(m)	$14.49K
2013-12-31	Reported	(m)	-$209.97K	(m)	(m)	(m)	(m)	(m)	(m)	$325.01K	(m)	(m)
2013-09-30	Reported	(m)	-$159.97K	(m)	(m)	(m)	$36.73K*	$79.37K*	(m)	$290.85K	(m)	$19.57K
2013-06-30	Reported	(m)	$23.72K	(m)	(m)	(m)	$74.46K*	$490.15K*	(m)	$271.86K	(m)	$4.02K
2013-03-31	Reported	(m)	$326.67K	(m)	(m)	(m)	$8.95K	$445.30K	(m)	$266.48K	(m)	$166.39K
2012-12-31	Reported	(m)	$12.50K	(m)	(m)	(m)	(m)	(m)	(m)	$234.32K	(m)	(m)
2012-09-30	Reported	(m)	-$86.13K	(m)	(m)	(m)	$12.62K*	-$137.49K*	(m)	$223.77K	(m)	-$30.82K
2012-06-30	Reported	(m)	$37.40K	(m)	(m)	(m)	$124.49K*	$126.96K*	(m)	$211.71K	(m)	$11.85K
2012-03-31	Reported	(m)	$281.23K	(m)	(m)	(m)	$112.46K	$191.85K	(m)	$247.81K	(m)	$115.96K
2011-12-31	Reported	(m)	$9.38K	(m)	(m)	(m)	(m)	(m)	(m)	$271.08K	(m)	(m)
2011-09-30	Reported	(m)	-$192.39K	(m)	(m)	(m)	$35.39K*	-$357.94K*	(m)	$304.08K	(m)	-$83.28K
2011-06-30	Reported	(m)	-$432.86K	(m)	(m)	(m)	$22.18K*	-$208.96K*	(m)	$672.76K	(m)	-$198.44K
2011-03-31	Reported	(m)	-$16.86K	(m)	(m)	(m)	$130.36K	$234.74K	(m)	$472.13K	(m)	-$8.38K
2010-09-30	Reported	(m)	-$347.54K	(m)	(m)	(m)	$15.99K*	-$112.67K*	(m)	$312.16K	(m)	$153.47K
2010-06-30	Reported	(m)	$47.63K	(m)	(m)	(m)	(m)	(m)	(m)	$333.32K	(m)	$30.28K

EBITDA 12 month

Date	Basis	EBITDA	Operating income	Depreciation and amortization	Revenue	EBITDA margin	Capital spending	Operating cash flow	Cost of products and services	Research and development	Selling, general and administration	Income tax expense / benefit
2025-12-31	Reported	$4.43M	(m)	(m)	(m)	16.04%	$1.25M	$2.48M	(m)	$3.04M	(m)	$11.57K
2024-12-31	Reported	$1.09M	(m)	(m)	(m)	4.11%	$465.73K	$357.90K	$18.55M	$3.90M	(m)	$10.06K
2023-12-31	Reported	-$3.01M*	-$5.75M	$2.74M	$17.47M	-17.22%*	$1.89M	-$4.67M	$13.60M	$4.39M	(m)	$4.63K
2022-12-31	Reported	(m)	-$2.30M	(m)	$18.57M	(m)	$3.98M	-$1.54M	$10.92M	$4.49M	(m)	$7.67K
2021-12-31	Reported	(m)	$257.38K	(m)	$19.24M	(m)	$2.61M	$954.17K	$10.59M	$4.17M	(m)	$9.16K
2020-12-31	Reported	(m)	-$1.38M	(m)	$15.34M	(m)	$4.07M	$1.32M	$8.48M	$4.35M	(m)	-$10.14K
2019-12-31	Reported	(m)	-$953.91K	(m)	(m)	(m)	$1.39M	$233.51K	$6.98M	$3.69M	(m)	$28.17K
2018-12-31	Reported	(m)	-$1.45M	(m)	(m)	(m)	$2.03M	-$373.40K	$5.79M	$3.52M	(m)	$461.62K
2017-12-31	Reported	(m)	-$242.84K	(m)	(m)	(m)	$17.76M	$1.18M	$5.21M	$2.05M	(m)	-$270.33K
2017-09-30	Rolling	(m)	$289.80K*	(m)	(m)	(m)	(m)	(m)	(m)	$1.57M*	(m)	(m)
2017-06-30	Rolling	(m)	$822.68K*	(m)	(m)	(m)	(m)	(m)	(m)	$1.29M*	(m)	(m)
2017-03-31	Rolling	(m)	$1.11M*	(m)	(m)	(m)	(m)	(m)	(m)	$1.28M*	(m)	(m)
2016-12-31	Reported	(m)	$890.20K	(m)	(m)	(m)	$3.59M	-$222.31K	(m)	$1.24M	(m)	$249.87K
2016-12-31	Rolling	(m)	$890.21K*	(m)	(m)	(m)	(m)	(m)	(m)	$1.24M*	(m)	(m)
2016-09-30	Rolling	(m)	$1.23M*	(m)	(m)	(m)	(m)	(m)	(m)	$1.32M*	(m)	(m)
2016-06-30	Rolling	(m)	$1.81M*	(m)	(m)	(m)	(m)	(m)	(m)	$1.32M*	(m)	(m)
2016-03-31	Rolling	(m)	$2.00M*	(m)	(m)	(m)	(m)	(m)	(m)	$1.21M*	(m)	(m)
2015-12-31	Reported	(m)	$2.12M	(m)	(m)	(m)	$2.72M	$2.90M	(m)	$1.24M	(m)	$850.31K
2015-12-31	Rolling	(m)	$2.12M*	(m)	(m)	(m)	(m)	(m)	(m)	$1.24M*	(m)	(m)
2015-09-30	Rolling	(m)	$1.86M*	(m)	(m)	(m)	(m)	(m)	(m)	$1.37M*	(m)	(m)
2015-06-30	Rolling	(m)	$1.27M*	(m)	(m)	(m)	(m)	(m)	(m)	$1.43M*	(m)	(m)
2015-03-31	Rolling	(m)	$601.09K*	(m)	(m)	(m)	(m)	(m)	(m)	$1.92M*	(m)	(m)
2014-12-31	Reported	(m)	-$206.40K	(m)	(m)	(m)	$1.54M	$302.36K	(m)	$2.18M	(m)	-$88.29K
2014-12-31	Rolling	(m)	-$206.40K*	(m)	(m)	(m)	(m)	(m)	(m)	$2.18M*	(m)	(m)
2014-09-30	Rolling	(m)	-$615.23K*	(m)	(m)	(m)	(m)	(m)	(m)	$2.04M*	(m)	(m)
2014-06-30	Rolling	(m)	-$816.05K*	(m)	(m)	(m)	(m)	(m)	(m)	$1.97M*	(m)	(m)
2014-03-31	Rolling	(m)	-$333.66K*	(m)	(m)	(m)	(m)	(m)	(m)	$1.48M*	(m)	(m)
2013-12-31	Reported	(m)	-$19.55K	(m)	(m)	(m)	$597.70K	$1.10M	(m)	$1.15M	(m)	$87.86K
2013-12-31	Rolling	(m)	-$19.55K*	(m)	(m)	(m)	(m)	(m)	(m)	$1.15M*	(m)	(m)
2013-09-30	Rolling	(m)	$202.92K*	(m)	(m)	(m)	(m)	(m)	(m)	$1.06M*	(m)	(m)
2013-06-30	Rolling	(m)	$276.76K*	(m)	(m)	(m)	(m)	(m)	(m)	$996.42K*	(m)	(m)
2013-03-31	Rolling	(m)	$290.43K*	(m)	(m)	(m)	(m)	(m)	(m)	$936.27K*	(m)	(m)
2012-12-31	Reported	(m)	$245.00K	(m)	(m)	(m)	$275.39K	$344.39K	(m)	$917.60K	(m)	$102.64K
2012-12-31	Rolling	(m)	$245.00K*	(m)	(m)	(m)	(m)	(m)	(m)	$917.60K*	(m)	(m)
2012-09-30	Rolling	(m)	$241.89K*	(m)	(m)	(m)	(m)	(m)	(m)	$954.36K*	(m)	(m)
2012-06-30	Rolling	(m)	$135.62K*	(m)	(m)	(m)	(m)	(m)	(m)	$1.03M*	(m)	(m)
2012-03-31	Rolling	(m)	-$334.63K*	(m)	(m)	(m)	(m)	(m)	(m)	$1.50M*	(m)	(m)
2011-12-31	Reported	(m)	-$632.73K	(m)	(m)	(m)	$243.74K	-$37.31K	(m)	$1.72M	(m)	-$287.17K
2011-12-31	Rolling	(m)	-$632.73K*	(m)	(m)	(m)	(m)	(m)	(m)	$1.72M*	(m)	(m)
2010-12-31	Reported	(m)	-$690.28K	(m)	(m)	(m)	$116.55K	-$808.61K	(m)	$1.49M	(m)	-$298.73K
2009-12-31	Reported	(m)	-$529.91K	(m)	(m)	(m)	$459.55K	-$109.67K	(m)	$1.64M	(m)	-$212.01K

Similar stocks

Stock Name	Country	Market Cap	PE Ratio
Insight Molecular Diagnostics Inc. (IMDX)	United States	$0.129B	-3.90
BIOMERICA INC (BMRA)	United States	$0.011B
Q/C TECHNOLOGIES, INC. (QCLS)	United States	$0.008B	-1.93
Cardio Diagnostics Holdings, Inc. (CDIO)	United States	$0.006B
VOLITIONRX LTD (VNRX)		$0.003B	-0.64
MYRIAD GENETICS INC (MYGN)	United States	$0.397B	-4.84
Alpha Teknova, Inc. (TKNO)	United States	$0.500B	-18.12
QuidelOrtho Corp (QDEL)	United States	$0.733B	-0.90
ACHIEVE LIFE SCIENCES, INC. (ACHV)	United States	$0.806B	-5.88
Intellia Therapeutics, Inc. (NTLA)	United States	$1.705B	-5.92